• Wrong document? Swap it for free
  • Written by students who passed
  • Immediately available after payment
  • Read online or as PDF
Sell
Where do you study
Your language
Document preview thumbnail
Preview 3 out of 26 pages
Exam (elaborations)

PHARM 202Pharm Test Pharm_Test__3

Document preview thumbnail
Preview 3 out of 26 pages

A 2-year-old child has chronic "toddler's" diarrhea, which has an unknown but benign etiology. The child's parent asks the primary care NP if a medication can be used to treat the child's symptoms. The NP should recommend giving: a. diphenoxylate (Lomotil). b. bismuth subsalicylate (Pepto-Bismol). c. attapulgite (Kaopectate). d. an electrolyte solution (Pedialyte). d. an electrolyte solution (Pedialyte). Antidiarrheals are not recommended in children. Opioids are contraindicated in children younger than 2 years. Bismuth and attapulgite are not recommended in children younger than 3 years of age. Oral rehydration with electrolyte solution is safe for young children. A 5-year-old child has chronic constipation. The primary care NP plans to prescribe a laxative for long-term management. In addition to pharmacologic therapy, the NP should also recommend _____ g of fiber per day. a. 20 b. 15 c. 10 d. 25 c. 10 Each day a child should receive 1 g of fiber per year of age plus 5 g after 2 years of age. A 12-year-old patient has acute diarrhea and an upper respiratory infection. Other family members have had similar symptoms, which have resolved. The primary care NP should recommend: a. attapulgite (Kaopectate). b. bismuth subsalicylate (Pepto-Bismol). c. an electrolyte solution (Pedialyte). d. diphenoxylate (Lomotil). c. an electrolyte solution (Pedialyte). Antidiarrheals are not generally recommended in children. Bismuth is not recommended in children younger than 16 years of age with viral illnesses because it can mask symptoms of Reye's syndrome. Oral rehydration with electrolyte solution is safe. A 45-year-old patient who has a positive family history but no personal history of coronary artery disease is seen by the primary care NP for a physical examination. The patient has a body mass index of 27 and a blood pressure of 130/78 mm Hg. Laboratory tests reveal low-density lipoprotein, 110 mg/dL; high-density lipoprotein, 70 mg/dL; and triglycerides, 120 mg/dL. The patient does not smoke but has a sedentary lifestyle. The NP should recommend: a. 30 minutes of aerobic exercise daily. b. beginning therapy with a statin medication. c. taking 81 to 325 mg of aspirin daily. d. starting a thiazide diuretic to treat hypertension. a. 30 minutes of aerobic exercise daily. This patient is overweight but not obese, and blood lipids are within normal limits. Blood pressure is not elevated. Exercise is recommended as an initial risk reduction strategy because of its positive effects on blood pressure and blood lipids. Aspirin is generally given to patients older than 55 to 65 who are at risk. Statin medications and thiazide diuretics are not indicated. A 50-year-old patient who recently quit smoking reports a frequent morning cough productive of yellow sputum. A chest xray is clear, and the patient's FEV1 is 80% of predicted. Pulse oximetry reveals an oxygen saturation of 97%. The primary care NP auscultates clear breath sounds. The NP should: a. order a long-acting anticholinergic with albuterol twice daily. b. prescribe a moderate-dose ICS twice daily. c. prescribe an albuterol metered-dose-inhaler, 2 puffs every 4 hours as needed. d. reassure the patient that these symptoms will subside. c. prescribe an albuterol metered-dose-inhaler, 2 puffs every 4 hours as needed. For patients with stable COPD having respiratory symptoms with FEV1 between 60% and 80% of predicted, inhaled bronchodilators may be used. COPD is not reversible, and the symptoms will not subside. ICS therapy or long-acting anticholinergics are recommended when FEV1 is less than 60%.A 55-year-old patient with no prior history of hypertension has a blood pressure greater than 140/90 on three separate occasions. The patient does not smoke, has a body mass index of 24, and exercises regularly. The patient has no known risk factors for cardiovascular disease. The primary care NP should: a. order a urinalysis and creatinine clearance and begin therapy with a b-blocker. b. prescribe a thiazide diuretic and an angiotensin-converting enzyme inhibitor. c. perform a careful cardiovascular physical assessment. d. counsel the patient about dietary and lifestyle changes. c. perform a careful cardiovascular physical assessment. If the patient is younger than 20 or older than 50 years old at the onset of elevated blood pressure, the NP should look for causes of secondary hypertension. The physical examination should include a careful cardiovascular assessment. This patient will need pharmacologic treatment, but not until the underlying cause of hypertension is determined. A 55-year-old woman has a history of myocardial infarction (MI). A lipid profile reveals LDL of 130 mg/dL, HDL of 35 mg/dL, and triglycerides 150 mg/dL. The woman is sedentary with a body mass index of 26. The woman asks the primary care NP about using a statin medication. The NP should: a. recommend dietary and lifestyle changes first. b. discuss quality-of-life issues as part of the decision to begin medication. c. tell her there is no clinical evidence of efficacy of statin medication in her case. d. begin therapy with atorvastatin 10 mg per day. d. begin therapy with atorvastatin 10 mg per day. This woman would be using a statin medication for secondary prevention because she already has a history of MI, so a statin should be prescribed. Dietary and lifestyle changes should be a part of therapy, but not the only therapy. She is relatively young, and quality-of-life issues are not a concern. There is no clinical evidence to support use of statins as primary prevention in women. A 70-year-old patient asks an NP about using diphenhydramine (Benadryl) to control intermittent allergic symptoms that include runny nose and sneezing. The NP should counsel this patient to: a. monitor for hypertension while taking the drug. b. watch for symptoms of paradoxical excitation with this medication. c. take the lowest recommended dose initially. d. take the antihistamine with a decongestant for best effect. c. take the lowest recommended dose initially. Antihistamines are more likely to cause excessive sedation, syncope, dizziness, confusion, and hypotension in elderly patients; a decrease in dose is usually necessary. Hypotension is likely; there is no need to monitor for hypertension. This patient does not have symptoms of congestion. Paradoxical excitation occurs in some young children but is not an identified risk in elderly patients. A 70-year-old patient who has COPD takes theophylline daily and uses a SABA for exacerbation of symptoms. The patient reports using the SABA three or four times each week when short of breath. The patient reports feeling jittery and nauseated and having trouble sleeping. The primary care NP should: a. obtain a serum theophylline level. b. prescribe a leukotriene modifier instead of theophylline. c. order a creatinine clearance level. d. discontinue the SABA and change to ipratropium bromide. a. obtain a serum theophylline level. Nausea, vomiting, insomnia, jitteriness, and other symptoms may indicate theophylline toxicity. Serum concentration monitoring should be done whenever signs of toxicity are suspected. A serum creatinine clearance level is not indicated. Leukotriene modifiers are not used for COPD. Ipratropium is used as an adjunct to the SABA during acute exacerbations. A 75-year-old patient requires frequent use of corticosteroids to control COPD exacerbations. To monitor adverse drug effects in this patient, the primary care NP should: a. order an electrocardiogram to assess for arrhythmias. b. order routine chest radiographs to watch for pneumonia. c. order a bone density study. d. monitor the patient's renal function at every visit. c. order a bone density study. High-dose ICSs and oral corticosteroids that are often used in COPD may cause or worsen osteoporosis in an older adult. The NP should order a bone density study.An 80-year-old male patient will begin taking an a-antiadrenergic medication. The primary care NP should teach this patient to: a. ask for assistance while bathing. b. be aware that priapism is a common side effect. c. take the medication in the morning with food. d. restrict fluids to aid with diuresis. a. ask for assistance while bathing. All antihypertensives can cause orthostatic hypotension, so patients should be cautioned to avoid sudden changes in position and to use caution when bathing because a hot bath or shower may aggravate dizziness. Older patients are at increased risk for falls and should be cautioned to ask for assistance. Patients taking a-antiadrenergics should consume extra fluids because dehydration can increase the risk of orthostatic hypotension. Patients should take the medication at bedtime because drowsiness is a common side effect. Priapism is not a side effect of these drugs. An 80-year-old patient asks a primary care NP about OTC antacids for occasional heartburn. The NP notes that the patient has a normal complete blood count and normal electrolytes and a slight elevation in creatinine levels. The NP should recommend: a. magnesium hydroxide (Milk of Magnesia). b. aluminum hydroxide (Amphojel). c. sodium bicarbonate (Alka-Seltzer). d. calcium carbonate (Tums). d. calcium carbonate (Tums). Elderly patients with renal failure should not take antacids containing magnesium because of the risk of hypermagnesemia. Sodium-containing antacids may cause fluid retention in elderly patients. Aluminum hydroxide is not as effective as calcium carbonate. An 80-year-old patient has a history of renal disease and develops a duodenal ulcer. The primary care NP should order a: a. decreased dose of a PPI. b. normal dose of a PPI. c. decreased dose of a histamine-2 blocker. d. normal dose of a histamine-2 blocker. b. normal dose of a PPI. No adjustment of dosage is necessary for older patients taking PPIs. Patients with a history of renal disease may have decreased elimination of histamine-2 blockers, so the NP should avoid these if possible. An 80-year-old patient has begun taking propranolol (Inderal) and reports feeling tired all of the time. The primary care NP should: a. tell the patient to stop taking the medication immediately. b. recommend that the patient take the medication at bedtime. c. tell the patient that tolerance to this side effect will occur over time. d. contact the patient's cardiologist to discuss decreasing the dose of propranolol. d. contact the patient's cardiologist to discuss decreasing the dose of propranolol. Elderly patients have described sedation and sleep disturbances with b-blockers. Elderly patients often need lower doses of these drugs. Patients should not be advised to discontinue the medication abruptly. An 80-year-old patient who has persistent AF takes warfarin (Coumadin) for anticoagulation therapy. The patient has an INR of 3.5. The primary care NP should consider: a. omitting a dose and resuming at a lower dose. b. omitting a dose and administering 1 mg of vitamin K. c. lowering the dose of warfarin. d. rechecking the INR in 1 week. d. rechecking the INR in 1 week. This patient's INR is only minimally prolonged, so no dose reduction is required. The NP should recheck the INR periodically. If the INR becomes more prolonged, lowering the dose of warfarin is recommended. If the INR approaches 5, omitting a dose and resuming at a lower dose is recommended. Vitamin K is used for an INR of 9 or greater.An 80-year-old patient with chronic stable angina has begun taking nadolol (Corgard) 20 mg once daily in addition to taking nitroglycerin as needed. After 1 week, the patient reports no change in frequency of nitroglycerin use. The primary care nurse practitioner (NP) should change the dose of nadolol to _____ mg _____ daily. a. 20; twice b. 40; twice c. 80; once d. 40; once d. 40; once b-Blockers are the treatment of choice for chronic stable and unstable angina. Their therapeutic effect is dose dependent, and drug titration should be based on frequency of angina symptoms and nitroglycerin use. Nadolol should be started at 20 mg daily for elderly patients when treating angina and should be increased by 20 mg every 3 to 7 days if symptoms do not improve. Nadolol is given once daily. An African-American patient is taking captopril (Capoten) 25 mg twice daily. When performing a physical examination, the primary care nurse practitioner (NP) learns that the patient continues to have blood pressure readings of 135/90 mm Hg. The NP should: a. change the drug to losartan (Cozaar) 50 mg once daily. b. increase the captopril dose to 50 mg twice daily. c. add a thiazide diuretic to this patient's regimen. d. recommend a low-sodium diet in addition to the medication c. add a thiazide diuretic to this patient's regimen. Some African-American patients do not appear to respond as well as whites in terms of blood pressure reduction. The addition of a low-dose thiazide diuretic often allows for efficacy in blood pressure lowering that is comparable with that seen in white patients. Increasing the captopril dose is not indicated. Losartan is an angiotensin receptor blocker (ARB) and is not indicated in this case. An African-American patient who is obese has persistent blood pressure readings greater than 150/95 mm Hg despite treatment with a thiazide diuretic. The primary care NP should consider prescribing a(n): a. b-blocker. b. angiotensin receptor blocker. c. ACE inhibitor. d. calcium channel blocker. d. calcium channel blocker. African-American patients are considered good candidates for calcium channel blockers to treat hypertension. Treatment with calcium channel blockers as monotherapy in African-American patients has proved to be more effective than some other classes of antihypertensive agents. A child with chronic allergic symptoms uses an intranasal steroid for control of symptoms. At this child's annual well-child checkup, the NP should carefully review this child's: a. height and weight. b. blood pressure. c. liver function tests. d. urinalysis. a. height and weight. Intranasal corticosteroids can cause growth suppression in children. When using intranasal steroids in children, the lowest dosage should be used for the shortest period of time necessary, and growth should be routinely monitored. It is not necessary to evaluate urine, blood pressure, or liver function because of intranasal steroid use. A female patient who is underweight tells the primary care NP that she has been using bisacodyl (Dulcolax) daily for several years. The NP should: a. counsel the patient to discontinue the laxative and increase fluid and fiber intake. b. tell her that long-term use of suppositories is safer than long-term laxative use. c. suggest she use polyethylene glycol (MiraLAX) on a daily basis instead. d. prescribe docusate sodium (Colace) and decrease bisacodyl gradually. d. prescribe docusate sodium (Colace) and decrease bisacodyl gradually. Patients who abuse laxatives are at risk for cathartic colon and for electrolyte imbalances. These patients should be weaned from their stimulant laxative and placed on safer long-term laxatives, such as a bulk laxative or stool softener. Polyethylene glycol is a stimulant. Long-term use of suppositories causes rectal irritation. Discontinuing the laxative without a long-term laxative will lead to rebound constipation.An NP prescribes azelastine for a patient who has allergic rhinitis. The NP will teach the patient that this drug: a. will cause rebound congestion if withdrawn suddenly. b. can cause many systemic side effects such as drowsiness. c. will not provide maximum relief for a few weeks. d. may cause a bitter aftertaste. d. may cause a bitter aftertaste Azelastine is a topical antihistamine with few adverse systemic side effects. Patients may experience relief from symptoms within 30 minutes. Decongestants can cause rebound congestion if withdrawn suddenly. Topical antihistamines rarely cause systemic side effects. An NP sees a patient who reports persistent seasonal symptoms of rhinorrhea, sneezing, and nasal itching every spring unrelieved with diphenhydramine (Benadryl). The NP should prescribe: a. triamcinolone (Nasacort AQ). b. cromolyn sodium (Nasalcrom). c. azelastine (Astelin). d. phenylephrine (Neo-Synephrine) a. triamcinolone (Nasacort AQ) According to randomized controlled trials in patients with allergic rhinitis, oral antihistamines are used first to help control itching, sneezing, rhinorrhea, and stuffiness in most patients. Intranasal corticosteroids are indicated for patients who do not respond to antihistamines. Azelastine is a topical antihistamine. Phenylephrine is a decongestant, and this patient does not have congestion. Cromolyn sodium is less effective than intranasal corticosteroids. A parent asks an NP which over-the-counter medication would be best to give to a 5-year-old child who has a viral respiratory illness with nasal congestion and a cough. The NP should recommend which of the following? a. Increased fluids with a teaspoon of honey b. An antitussive/expectorant combination such as Robitussin DM c. Diphenhydramine (Benadryl) d. Over-the-counter pseudoephedrine with guaifenesin (Sudafed) a. Increased fluids with a teaspoon of honey Nonpharmacologic treatments are recommended for children younger than 6 years. Adequate hydration can decrease cough, thin secretions, and hydrate tissues. A teaspoon of honey has been shown to be effective in reducing cough in small children. Diphenhydramine is an antihistamine that dries nasal secretions but does not aid in decongestion. Sudafed and Robitussin are not recommended in children younger than 6 years. A patient asks an NP about using an oral over-the-counter decongestant medication for nasal congestion associated with a viral upper respiratory illness. The NP learns that this patient uses loratadine (Claritin), a b-adrenergic blocker, and an intranasal corticosteroid. The NP would be concerned about which adverse effects? a. Rebound congestion b. Liver toxicity c. Excessive drowsiness d. Tremor, restlessness, and insomnia d. Tremor, restlessness, and insomnia b-Adrenergic blockers and monoamine oxidase inhibitors may potentiate the effects of decongestants, such as tremor, restlessness, and insomnia. Liver toxicity, excessive drowsiness, and rebound congestion are not known adverse effects of drug interactions. A patient comes to the clinic with a 3-day history of fever and a severe cough that interferes with sleep. The patient asks the NP about using a cough suppressant to help with sleep. The NP should: a. suggest that the patient try a guaifenesin-only over-thecounter product. b. prescribe an antibiotic to treat the underlying cause of the patient's cough. c. order a narcotic antitussive to suppress cough. d. obtain a thorough history of the patient's symptoms. d. obtain a thorough history of the patient's symptoms. It is important to determine the underlying disorder that is causing the cough to rule out serious causes of cough. The NP should obtain a thorough history before prescribing any treatment. A narcotic antitussive may be used after serious causes are ruled out. Guaifenesin may be used to make nonproductive coughs more productive. Antibiotics are indicated only for a proven bacterial infection.A patient comes to the clinic with a 4-day history of 10 to 12 liquid stools each day. The patient reports seeing blood and mucus in the stools. The patient has had nausea but no vomiting. The primary care NP notes a temperature of 37.9° C, a heart rate of 96 beats per minute, and a blood pressure of 90/60 mm Hg. A physical examination reveals dry oral mucous membranes and capillary refill of 4 seconds. The NP's priority should be to: a. administer opioid antidiarrheal medications. b. obtain stool cultures. c. consider prescribing metronidazole. d. begin rehydration therapy. d. begin rehydration therapy. Acute diarrhea is usually mild and self-limited. Nonpharmacologic measures, especially bowel rest and adequate hydration, are helpful and should be a priority. Stool cultures may be ordered after hydration therapy is begun. Metronidazole is indicated if C. difficile is present. Opioid antidiarrheals may prolong symptoms. A patient comes to the clinic with a complaint of gradual onset of left-sided weakness. The primary care NP notes slurring of the patient's speech. A family member accompanying the patient tells the NP that these symptoms began 4 or 5 hours ago. The NP will activate the emergency medical system and expect to administer: a. warfarin (Coumadin) and aspirin. b. 325 mg of chewable aspirin. c. LMWH. d. intravenous alteplase and aspirin. b. 325 mg of chewable aspirin. Alteplase is used to treat ischemic stroke but is contraindicated if onset of symptoms occurred 3 hours previously. The administration of anticoagulation or antiplatelet agents during the first 24 hours is not recommended. The oral administration of aspirin within 24 to 48 hours after stroke onset is recommended. A patient comes to the clinic with a history of syncope and weakness for 2 to 3 days. The primary care NP notes thready, rapid pulses and 3-second capillary refill. An ECG reveals a heart rate of 198 beats per minute with a regular rhythm. The NP should: a. order digoxin and verapamil and ask the patient to return for a follow-up examination in 1 week. b. administer intravenous fluids and obtain serum electrolytes. c. send the patient to an emergency department for evaluation and treatment. d. administer amiodarone in the clinic and observe closely for response. c. send the patient to an emergency department for evaluation and treatment. Paroxysmal supraventricular tachycardia (PSVT) is a very fast regular rate and rhythm. This patient is becoming decompensated and should be referred to the emergency department for evaluation and treatment. The primary care NP should not treat this in the clinic or as an outpatient until the patient is stable. A patient comes to the clinic with a recent onset of nocturnal and exertional dyspnea. The primary care nurse practitioner (NP) auscultates S3 heart sounds but does not palpate hepatomegaly. The patient has mild peripheral edema of the ankles. The NP should consult a cardiologist to discuss prescribing a(n): a. b-blocker. b. angiotensin receptor blocker (ARB). c. loop diuretic. d. angiotensin-converting enzyme (ACE) inhibitor. c. loop diuretic. This patient shows signs of systolic heart failure. Treatment for heart failure should begin with a loop diuretic, with an ACE inhibitor added after the diuretic has been taken. b-Blockers are used in patients with minimal fluid retention and would be added later. ARBs are used if ACE inhibitors are not tolerated or are ineffective. A patient has been diagnosed with IBS and tells the primary care NP that symptoms of diarrhea and cramping are worsening. The patient asks about possible drug therapy to treat the symptoms. The NP should prescribe: a. dicyclomine (Bentyl). b. simethicone (Phazyme). c. metoclopramide (Reglan). d. mesalamine (Asacol). a. dicyclomine (Bentyl). Dicyclomine has indirect and direct effects on the smooth muscle of the gastrointestinal (GI) tract. Both actions help to relieve smooth muscle spasm. Mesalamine is used to treat ulcerative colitis. Simethicone acts locally to treat symptoms of trapped air and gas. Metoclopramide is used to increase motility.A patient has been taking antibiotics to treat recurrent pneumonia. The patient is in the clinic after having diarrhea for 5 days with six to seven liquid stools each day. The primary care NP should: a. order testing for Clostridium difficile and consider metronidazole therapy. b. obtain a stool specimen and order vancomycin. c. prescribe diphenoxylate (Lomotil) to provide symptomatic relief. d. reassure the patient that diarrhea is a common side effect of antibiotic therapy. a. order testing for Clostridium difficile and consider metronidazole therapy. The guidelines for treatment of diarrhea emphasize comprehensive evaluation before treatment begins. Antibiotic use points to C. difficile as a possible cause, and metronidazole is often used to treat mild to moderate infection. Vancomycin is used when C. difficile is severe. Diphenoxylate can worsen the infection because it slows transit time of the bacteria in the gut. Prolonged diarrhea during antibiotic therapy should be investigated. A patient has heart failure. A recent echocardiogram reveals decreased compliance of the left ventricle and poor ventricular filling. The patient takes low-dose furosemide and an ACE inhibitor. The primary care NP sees the patient for a routine physical examination and notes a heart rate of 92 beats per minute and a blood pressure of 100/60 mm Hg. The NP should: a. order serum electrolytes. b. obtain renal function tests. c. consider prescribing a b-blocker. d. call the patient's cardiologist to discuss adding digoxin to the patient's regimen. a. order serum electrolytes. Patients with diastolic heart failure are sensitive to fluid depletion, which can cause decreased preload and stroke volume. This patient has a rapid heart rate and a low blood pressure, which can indicate dehydration, so serum electrolytes should be obtained. Renal function tests are not indicated. b-Blockers are used in patients who are stable. Digoxin should not be used in patients with diastolic failure. A patient has NSAID-induced ulcer and has started taking ranitidine (Zantac). At a follow-up appointment 3 days later, the patient reports no alleviation of symptoms. The primary care NP should: a. change from ranitidine to omeprazole (Prilosec). b. reassure the patient that drug effects take several weeks. c. order cimetidine (Tagamet). d. add metronidazole to the drug regimen. a. change from ranitidine to omeprazole (Prilosec). If the patient does not start to see improvement within a few days after initiation of treatment with a histamine-2 blocker, the provider either should increase the dose of the medication or should change to a PPI. Cimetidine is a histamine-2 blocker and has many serious side effects. Metronidazole is used only when H. pylori is known to be present. Patients should start to get relief within a few days. A patient has three consecutive blood pressure readings of 140/95 mm Hg. The patient's body mass index is 24. A fasting plasma glucose is 100 mg/dL. Creatinine clearance and cholesterol tests are normal. The primary care NP should order: a. a thiazide diuretic. b. an angiotensin-converting enzyme inhibitor. c. a b-blocker. d. dietary and lifestyle changes. a. a thiazide diuretic. The patient has stage I hypertension. Because there are no compelling indications for other treatment, a thiazide diuretic should be used initially to treat the hypertension. Dietary and lifestyle changes should also be recommended but are not sufficient for patients with stage I hypertension. Other drugs may be added later if thiazide diuretic therapy fails. A patient in the clinic develops sudden shortness of breath and tachycardia. The primary care NP notes thready pulses, poor peripheral perfusion, and a decreased level of consciousness. The NP activates the emergency medical system and should anticipate that this patient will receive: a. intravenous alteplase. b. unfractionated heparin (UFH) and warfarin. c. low-dose aspirin and warfarin. d. low-molecular-weight heparin (LMWH). a. intravenous alteplase. This patient has unstable pulmonary embolism (PE) and should receive thrombolytic therapy. Intravenous alteplase is the preferred agent. UFH and warfarin are recommended for stable PE. LMWH is beneficial in submassive PE and deep vein thrombosis (DVT) but is controversial for treatment of massive PE.A patient in the clinic reports frequent episodes of bloating, abdominal pain, and loose stools to the primary care nurse practitioner (NP). An important question the NP should ask about the abdominal pain is: a. whether the pain is sharp or diffuse. b. the age of the patient when the pain began. c. the relation of the pain to stools. d. what time of day the pain occurs. c. the relation of the pain to stools. The new Rome II guidelines maintain that irritable bowel syndrome (IBS) of any subtype is characterized by a strong relationship between abdominal pain and defecation because of visceral hypersensitivity to gutrelated events. The other characteristics of pain may be assessed to help guide management of IBS, but the first is necessary for a correct diagnosis. A patient in the clinic reports heartburn 30 minutes after meals, a feeling of fullness, frequent belching, and a constant sour taste. The patient has a normal weight and reports having a high-stress job. The primary care NP should recommend: a. changes in diet to avoid acidic foods. b. daily treatment with a PPI. c. antacid therapy as needed. d. consultation with a gastroenterologist for endoscopy. b. daily treatment with a PPI. This patient has symptoms of GERD. PPIs are first-line medications for treating GERD and may be started empirically. Antacids are not first-line medications. Changes in diet are not recommended as treatment but may help with symptoms. Patients with symptoms unrelieved by PPIs should be referred for possible endoscopy. A patient is given a diagnosis of peptic ulcer disease. A laboratory test confirms the presence of Helicobacter pylori. The primary care NP orders a proton pump inhibitor (PPI) before meals twice daily, clarithromycin, and amoxicillin. After 14 days of treatment, H. pylori is still present. The NP should order: a. a PPI, amoxicillin, and metronidazole for 14 days. b. continuation of the PPI for 4 to 8 weeks. c. a PPI, bismuth subsalicylate, tetracycline, and metronidazole. d. a PPI, clarithromycin, and amoxicillin for 14 more days. a. a PPI, amoxicillin, and metronidazole for 14 days. A PPI, along with amoxicillin and metronidazole, is used as first-line treatment in macrolideallergic patients and for re-treatment for 14 days if first-line treatment of choice failed because of occasional resistance to clarithromycin. A patient is in the clinic complaining of nausea and vomiting that has lasted 2 to 3 days. The patient has dry oral mucous membranes, a blood pressure of 90/56 mm Hg, a pulse of 96 beats per minute, and a temperature of 38.8° C. The primary care NP notes a capillary refill of greater than 3 seconds. The NP should: a. prescribe a rectal antiemetic medication. b. encourage the patient to take small, frequent sips of Gatorade. c. admit to the hospital for intravenous (IV) rehydration. d. obtain a complete blood count and serum electrolytes. c. admit to the hospital for intravenous (IV) rehydration. If vomiting is not controlled, dehydration may occur. Patients who are dehydrated, as this patient is, must be treated with IV fluids in a hospital or emergency department setting. A patient is in the clinic for a follow-up examination after a myocardial infarction (MI). The patient has a history of left ventricular systolic dysfunction. The primary care NP should expect this patient to be taking: a. carvedilol (Coreg). b. timolol (Blocadren). c. propranolol (Inderal). d. nadolol (Corgard). a. carvedilol (Coreg). The 2012 guides for prevention of cardiovascular disease recommend that b-blocker therapy should be used in all patients with left ventricular systolic dysfunction with heart failure or prior MI. Use should be limited to carvedilol, metoprolol succinate, or bisoprolol.A patient is in the clinic for an annual physical examination. The primary care NP obtains a medication history and learns that the patient is taking a b-blocker and nitroglycerin. The NP orders laboratory tests, performs a physical examination, and performs a review of systems. Which finding may warrant discontinuation of the b-blocker in this patient? a. Decreased exercise tolerance b. Nausea, vomiting, and anorexia c. Wheezing, dyspnea, and cough d. Increased triglycerides c. Wheezing, dyspnea, and cough b-Blockers may cause bronchospasm in susceptible patients, and discontinuation of the bblocker may be required. b-Blockers may cause an insignificant increase in serum triglycerides. Exercise intolerance, fatigue, and gastrointestinal side effects are common. A patient is taking a low-dose PPI for long-term management of GERD and reports taking sodium bicarbonate (Alka-Seltzer) to help with occasional heartburn. The primary care NP should tell the patient to: a. take calcium carbonate (Tums) instead of sodium bicarbonate (Alka-Seltzer). b. change to aluminum hydroxide (Amphojel). c. use magnesium hydroxide (Milk of Magnesia) instead. d. continue using sodium bicarbonate (Alka-Seltzer) as needed. a. take calcium carbonate (Tums) instead of sodium bicarbonate (Alka-Seltzer). Sodium bicarbonate is not suitable for long-term use because of side effects. Calcium carbonate requires monitoring when used long-term but has the highest acid-neutralizing capacity. Antacids containing aluminum and magnesium can cause electrolyte imbalances. A patient reports having episodes of dizziness, nausea, and lightheadedness and describes a sensation of the room spinning when these occur. The primary care NP will refer the patient to a specialist who, after diagnostic testing, is likely to prescribe: a. ondansetron. b. scopolamine. c. meclizine. d. dimenhydrinate. c. meclizine. Patients with vertigo may experience whirling or a feeling of the room spinning around. In true vertigo, the patient can identify the direction in which the room is spinning. Anticholinergics are the most effective agents in cases of motion sickness or vertigo. Meclizine has a specific indication to treat vertigo. A patient reports having occasional acute constipation with large, hard stools and pain and asks the primary care NP about medication to treat this condition. The NP learns that the patient drinks 1500 mL of water daily; eats fruits, vegetables, and bran; and exercises regularly. The NP should recommend: a. a daily bulk laxative. b. glycerin suppositories as needed. c. a saline laxative as needed. d. long-term docusate sodium. c. a saline laxative as needed. Mild short-term constipation may be treated with a saline laxative or a bulk laxative as needed. Daily laxatives are not recommended. Glycerin suppositories can cause irritation of the rectum with long-term use. A patient takes an antispasmodic and an occasional antidiarrheal medication to treat IBS. The patient comes to the clinic and reports having dry mouth, difficulty urinating, and more frequent constipation. The primary care NP notes a heart rate of 92 beats per minute. The NP should: a. discontinue the antidiarrheal medication. b. encourage the patient to increase water intake. c. lower the dose of the antispasmodic medication. d. prescribe a TCA. c. lower the dose of the antispasmodic medication. Patients taking antispasmodic medications should be monitored for anticholinergic side effects, such as increased heart rate, dry mouth, difficulty urinating, and constipation. The NP should lower the dose if needed. TCAs are used to treat pain long-term. Because the antidiarrheal medication is used as needed, there is no reason to discontinue it. Increasing water intake may improve symptoms associated with side effects but would not treat the underlying cause of these symptoms.A patient tells a nurse practitioner (NP) that several coworkers have upper respiratory infections and asks about the best way to avoid getting sick. The NP should recommend which of the following? a. Zinc gluconate supplements b. Frequent hand washing c. Echinacea d. Normal saline nasal irrigation B. Frequent hand washing. Hand washing is the most effective way to prevent the spread of viral upper respiratory illness (VURI). Echinacea has not been shown to be effective in preventing VURI. Zinc gluconate may decrease the duration of a VURI if taken within 24 hours of onset, but it does not prevent infection. Normal saline irrigation is helpful for symptomatic relief after a VURI has begun. A patient undergoes a routine electrocardiogram (ECG), which reveals occasional premature ventricular contractions that are present when the patient is resting and disappear with exercise. The patient has no previous history of cardiovascular disease, and the cardiovascular examination is normal. The primary care NP should: a. prescribe quinidine (Quinidex Extentabs). b. consider using amiodarone if the patient develops other symptoms. c. refer the patient to a cardiologist for further evaluation. d. tell the patient that treatment is not indicated d. tell the patient that treatment is not indicated. The most important factor in determining whether to treat premature ventricular contractions is the presence of underlying heart disease, such as myocardial ischemia, previous myocardial infarction, cardiac scarring or hypertrophy, or left ventricular dysfunction. Because of the risks associated with antiarrhythmic therapy, patients should not be treated unless clear indications are present. Premature ventricular contractions are not treated if the patient is asymptomatic, if the patient has a normal heart, if the premature ventricular contractions are simple, and if they disappear with exercise. Amiodarone is not used to treat acute premature ventricular contractions but is used for long-term prophylaxis. A patient undergoes endoscopy, and a diagnosis of erosive esophagitis is made. The patient does not have health insurance and asks the primary care NP about using OTC antacids such as Tums. The NP should tell the patient that Tums: a. neutralize stomach acid as well as proton pump inhibitors (PPIs) b. do not help reduce symptoms of erosive esophagitis. c. can help to heal erosions in esophageal tissue. d. help reduce symptoms in conjunction with PPIs. d. help reduce symptoms in conjunction with PPIs. Antacids reduce symptoms but do not have a significant effect on healing of erosions or esophagitis. If the patient has severe symptoms, has found treatment for milder symptoms to be ineffective, or has experienced erosion that is documented by endoscopy, he or she should be started on a PPI. A patient who has a history of angina has sublingual nitroglycerin tablets to use as needed. The primary care nurse practitioner (NP) reviews this medication with the patient at the patient's annual physical examination. Which statement by the patient indicates understanding of the medication? a. "I should take 3 nitroglycerin tablets 5 minutes apart and then call 9-1- 1." b. "I should call 9-1-1 if chest pain persists 5 minutes after the first dose." c. "I should take nitroglycerin and then rest for 15 minutes before taking the next dose." d. "I should take aspirin along with the nitroglycerin when I have chest pain." b. "I should call 9-1-1 if chest pain persists 5 minutes after the first dose." Although the traditional recommendation is for patients to take up to 3 nitroglycerin doses over 15 minutes before accessing emergency medical services (EMS), more recent guidelines suggest an alternative strategy to reduce delays in emergency care. These include instructions to call 9-1-1 immediately if pain persists for 5 minutes after the first dose. Aspirin is recommended when the patient is being transported to emergency care and is not recommended as an adjunct to nitroglycerin with each episode of chest pain. The three doses of nitroglycerin are given 5 minutes apart over 15 minutes. A patient who has a history of chronic constipation uses a bulk laxative to prevent episodes of acute constipation. The patient reports having an increased frequency of episodes. The primary care NP should recommend: a. adding docusate sodium (Colace). b. polyethylene glycol (MiraLAX) and bisacodyl (Dulcolax). c. adding nonpharmacologic measures such as biofeedback. d. lactulose (Chronulac) and polyethylene glycol (MiraLAX). a. adding docusate sodium (Colace). Patients treated for long-term constipation should begin with a bulk laxative. If that is not effective, the addition of a second laxative may be necessary. Using two laxatives from the same category is not recommended. A stool softener, such as docusate sodium, is appropriate. Bisacodyl is not a second-line treatment. Lactulose and polyethylene glycol are from the same category.A patient who has angina is taking nitroglycerin and long-acting nifedipine. The primary care NP notes a persistent blood pressure of 90/60 mm Hg at several follow-up visits. The patient reports lightheadedness associated with standing up. The NP should consult with the patient's cardiologist about changing the medication to: a. amlodipine (Norvasc). b. verapamil HCl (Calan). c. isradipine (DynaCirc). d. short-acting nifedipine (Procardia). b. verapamil HCl (Calan). Verapamil and diltiazem are less likely to cause hypotension than nifedipine and related drugs, such as isradipine and amlodipine. A patient who has angina uses 0.4 mg of sublingual nitroglycerin for angina episodes. The patient brings a log of angina episodes to an annual physical examination. The primary care NP notes that the patient has experienced an increase in frequency of episodes in the past month but no increase in duration or severity of pain. The NP should: a. increase the nitroglycerin dose to 0.6 mg per dose. b. contact the patient's cardiologist to discuss admission to the hospital. c. change from a sublingual to a transdermal patch nitroglycerin. d. discontinue the nitroglycerin and order ranolazine (Ranexa ER). b. contact the patient's cardiologist to discuss admission to the hospital. Unstable angina is a change in pattern or pain, such as an increase in frequency, severity, or duration of pain and fewer precipitating factors. Patients with unstable angina should be admitted to a coronary care unit. The primary care NP should not change any medications without consultation with the patient's cardiologist. A patient who has atrial fibrillation (AF) has been taking warfarin (Coumadin). The primary care nurse practitioner (NP) plans to change the patient's medication to dabigatran (Pradaxa). To do this safely, the NP should: a. start dabigatran 7 to 14 days after discontinuing warfarin. b. begin giving dabigatran 1 week before discontinuing warfarin. c. order frequent monitoring of the patient's INR after dabigatran therapy begins. d. initiate dabigatran when the patient's international normalized ratio (INR) is less than 2. d. initiate dabigatran when the patient's international normalized ratio (INR) is less than 2. There are no requirements for monitoring the INR or other measures for patients taking dabigatran. When changing from warfarin, it is recommended that dabigatran be initiated when the INR is less than 2. A patient who has been taking digoxin 0.25 mg daily for 6 months reports that it is not working as well as it did initially. The primary care NP should: a. contact the patient's pharmacy to ask if generic digoxin was dispensed. b. recommend a reduced potassium intake. c. hold the next dose of digoxin and obtain a serum digoxin level. d. increase the dose of digoxin to 0.5 mg daily. a. contact the patient's pharmacy to ask if generic digoxin was dispensed Clinicians should be aware that generic digoxin marketed by different companies may not be bioequivalent to the branded digoxin (Lanoxin). Patients with hyperkalemia would show intensified effects, not diminished effects of digoxin. Patients with diminished effects may have received a generic brand. It is not correct to increase the dose of digoxin without first obtaining a digoxin level. Because this patient is reporting decreased effects, it is unnecessary to suspect toxicity. A patient who has been taking propranolol for 6 months reports having nocturnal cough and shortness of breath. The primary care NP should: a. obtain serum drug levels to monitor for toxicity of this medication. b. contact the patient's cardiologist to discuss changing to a selective b-blocker. c. instruct the patient to increase activity and exercise to counter these side effects. d. tell the patient to stop taking the medication. b. contact the patient's cardiologist to discuss changing to a selective b-blocker. Nocturnal cough and shortness of breath may be a side effect of propranolol, which can cause bronchospasm because it is a nonselective â-blocker. The NP should discuss a selective bblocker with the patient's cardiologist. â-Blockers should never be stopped abruptly. Bradycardia and hypotension are signs of toxicity. Increasing activity would not counter these side effects if bronchospasm is the cause.A patient who has been taking quinidine for several years reports lightheadedness, fatigue, and weakness. The primary care NP notes a heart rate of 110 beats per minute. The serum quinidine level is 6 mg/mL. The NP should: a. admit the patient to the hospital and obtain a cardiology consultation. b. order an ECG, CBC, liver function tests (LFTs), and renal function tests. c. discontinue the medication immediately. d. reassure the patient that this is a therapeutic drug level. b. order an ECG, CBC, liver function tests (LFTs), and renal function tests. The therapeutic level for quinidine is 2 to 5 ìg/mL. Some patients have therapeutic responses at up to 6 mg/mL. The NP should order ECG, CBC, LFT, and renal function tests. A patient who has cerebral palsy is wheelchair dependent and receives enteral nutrition via a gastrostomy tube. The patient has infrequent, hard bowel movements despite using a high-fiber formula and receiving 1500 mL of fluid per day. The NP should order: a. docusate sodium (Colace). b. sodium phosphate (Fleets) enema. c. polyethylene glycol (MiraLAX). d. bisacodyl (Dulcolax). c. polyethylene glycol (MiraLAX). Fluids, fiber, and exercise, which help most people, are not applicable to people who are wheelchair bound. Other individuals with congestive heart failure are unable to tolerate these mechanisms. Osmotic laxatives, such as polyethylene glycol are used to manage long-term constipation. It is essential for clinicians to know their patients and assess what is reasonable for them to do. A patient who has diabetes is taking simvastatin (Zocor) 80 mg daily to treat LDL cholesterol level of 170 mg/dL. The patient has a body mass index of 29. At a follow-up visit, the patient's LDL level is 120 mg/dL. The primary care NP should consider: a. increasing the simvastatin to 80 mg twice daily. b. changing the medication to ezetimibe/simvastatin (Vytorin). c. referring the patient to a dietitian for assistance with weight reduction. d. adding nicotinic acid to the patient's drug regimen. b. changing the medication to ezetimibe/simvastatin (Vytorin). Patients with diabetes have a goal LDL of less than 100 mg/dL. If maximum-dose statin is unable to achieve the goal LDL, a combination product such as a statin plus ezetimibe is recommended. The maximum recommended dose is 80 mg daily, so increasing the dose to 80 mg twice daily is incorrect. A patient who has diabetic gastroparesis sees a gastroenterology specialist who orders metoclopramide (Reglan). Within 24 hours, the patient describes having extrapyramidal symptoms (EPS) to the primary care NP. The NP will contact the gastroenterologist and should expect to prescribe: a. an SSRI antidepressant. b. benztropine (Cogentin). c. a TCA. d. cimetidine. b. benztropine (Cogentin). Cogentin is indicated to treat EPS side effects of medications such as metoclopramide. The patient should be monitored during the first 24 to 48 hours for any adverse reactions. Should EPS occur, treat with intramuscular diphenhydramine (Benadryl) 50 mg or benztropine (Cogentin) 1 to 2 mg A patient who has disabling intermittent claudication is not a candidate for surgery. Which of the following medications should the primary care NP prescribe to treat this patient? a. Cilostazol (Pletal) b. Low-dose, short-term aspirin c. Warfarin (Coumadin) d. Pentoxifylline (Trental a. Cilostazol (Pletal) Patients with disabling intermittent claudication who are not candidates for surgery or catheterbased intervention should be treated with cilostazol rather than pentoxifylline. Warfarin is not indicated. Patients with chronic limb ischemia are treated with lifelong aspirin therapy.A patient who has experienced five to seven liquid stools for 3 days is seen in the clinic by the primary care NP. The patient reports having had fever, mucoid stools, and nausea without vomiting. The patient has been drinking Gatorade to stay hydrated. The NP obtains a stool specimen for culture and should prescribe: a. attapulgite (Kaopectate). b. loperamide hydrochloride (Imodium). c. bismuth subsalicylate (Pepto-Bismol). d. diphenoxylate (Lomotil). c. bismuth subsalicylate (Pepto-Bismol). Bismuth reduces symptoms through antidiarrheal and antibacterial properties and can decrease nausea and vomiting. Opioid antidiarrheals should be given after the cause of infectious diarrhea is treated; these can actually prolong symptoms because they slow transit of the causative organisms through the gut. Attapulgite can be used because it binds bacteria and toxins in the gastrointestinal tract, but bismuth is a better choice in this case because it helps to treat nausea. The patient is drinking Gatorade and is getting electrolyte replacement. A patient who has gastroesophageal reflux disease (GERD) undergoes an endoscopy, which shows a hiatal hernia. The patient is mildly obese. The patient asks the primary care nurse practitioner (NP) about treatment options. The NP should tell this patient that: a. a fundoplication will be necessary to correct the cause of GERD. b. a combination of lifestyle changes, medications, and surgery may be necessary. c. elevation of the head of the bed at night can relieve most symptoms. d. over-the-counter (OTC) antacids can be effective and should be tried first. b. a combination of lifestyle changes, medications, and surgery may be necessary. People with GERD often have hiatal hernia, but this is not the cause of GERD. The approach to treatment of GERD may include lifestyle changes, medications, and surgery. OTC antacids are sometimes used but are rarely used as first-line treatment. A patient who has GERD has been taking a PPI for 2 months and reports a slight decrease in symptoms. The next response of the primary care NP is to: a. refer the patient to an endocrinologist for endoscopy and further management. b. increase the dose of the PPI. c. add a histamine-2-receptor agonist. d. change to long-term, low-dose PPI therapy. c. add a histamine-2-receptor agonist. If treatment with a PPI is inadequate by 2 months, histamine-2-receptor agonist therapy is indicated. Increasing the dose is not indicated. Long-term, lower dose therapy is used for recurrences of symptoms on a limited basis. When symptoms fail to resolve with pharmacologic treatments, patients should be referred to an endocrinologist. A patient who has GERD with erosive esophagitis has been taking a PPI for 4 weeks and reports a decrease in symptoms. The patient asks the primary care NP if the medication may be discontinued. The NP should tell the patient that: a. the condition may eventually be cured, but therapy must continue for years. b. antireflux surgery must be done before the PPI can be discontinued. c. the dose may be decreased for long-term therapy. d. once the symptoms have cleared completely, the medication may be discontinued. c. the dose may be decreased for long-term therapy. Once PPIs have proven clinically effective for treatment of patients with esophagitis, therapy should be continued long-term and titrated down to the lowest effective dose based on symptom control. PPI therapy is considered safer than surgery and should be tried first before surgery is performed. GERD is a lifelong syndrome and is not curable. A patient who has had a new onset of AF the day prior will undergo cardioversion that day. The primary care NP will expect the cardiologist to: a. give warfarin and aspirin before attempting cardioversion. b. give low-dose aspirin before administering cardioversion. c. administer cardioversion without using anticoagulants. d. give clopidogrel after administering cardioversion. c. administer cardioversion without using anticoagulants. If the onset of AF has occurred within 48 hours, cardioversion can be done without anticoagulation. Clopidogrel is used in other cases for patients who cannot take aspirin. For patients with rheumatic mitral valve disease and AF or a history of systemic embolism, cardioversion plus aspirin is used. Warfarin is used in patients with one or more risk factors for stroke.A patient who has had a previous myocardial infarction has a blood pressure of 135/82 mm Hg. The patient's body mass index is 28, and the patient has a fasting plasma glucose of 105 mg/dL. The primary care NP should prescribe: a. a calcium-channel blocker. b. a thiazide diuretic. c. lifestyle modifications. d. an angiotensin-converting enzyme inhibitor. d. an angiotensin-converting enzyme inhibitor. This patient has prehypertension but has a compelling reason for treatment. Patients who have had a myocardial infarction should be treated with a b-blocker and angiotensinconverting enzyme inhibitor or angiotensin II receptor blocker (ARB). A patient who has had four to five liquid stools per day for 4 days is seen by the primary care NP. The patient asks about medications to stop the diarrhea. The NP tells the patient that antidiarrheal medications are: a. useful in cases of acute infection with elevated temperature. b. useful when other symptoms, such as hematochezia, develop. c. not curative and may prolong the illness. d. most beneficial when symptoms persist longer than 2 weeks. c. not curative and may prolong the illness. Treatment of patients with acute diarrhea with antidiarrheals can prolong infection and should be avoided if possible. Antidiarrheals are best used in patients with mild to moderate diarrhea and are used for comfort and not cure. They should not be used for patients with bloody diarrhea or high fever because they can worsen the disease. Prolonged diarrhea can indicate a more serious cause, and antidiarrheals should not be used in those cases. A patient who has heart failure has been treated with furosemide and an ACE inhibitor. The patient's cardiologist has added digoxin to the patient's medication regimen. The primary care NP who cares for this patient should expect to monitor: a. blood glucose levels. b. complete blood counts (CBCs). c. serum electrolytes. d. serum thyroid levels. c. serum electrolytes. Hypokalemia makes the myocardium more sensitive to digoxin. These levels should be monitored closely in patients taking furosemide, which can deplete potassium. Serum glucose, thyroid levels, and a CBC should be monitored if indicated by other conditions. A patient who has hyperlipidemia has been taking atorvastatin (Lipitor) 60 mg daily for 6 months. The patient's initial lipid profile showed LDL of 180 mg/dL, HDL of 45 mg/dL, and triglycerides of 160 mg/dL. The primary care NP orders a lipid profile today that shows LDL of 105 mg/dL, HDL of 50 mg/dL, and triglycerides of 120 mg/dL. The patient reports muscle pain and weakness. The NP should: a. order a creatine kinase-MM (CK-MM) level. b. change atorvastatin to twice-daily dosing. c. order liver function tests (LFTs). d. add gemfibrozil (Lopid) to the patient's medication regimen. a. order a creatine kinase-MM (CK-MM) level. Hepatotoxicity and muscle toxicity are the two primary adverse effects of greatest concern with statin use. Patients who report muscle discomfort or weakness should have a CK-MM level drawn. LFTs are indicated with signs of hepatotoxicity. It is not correct to change the dosing schedule. Gemfibrozil is not indicated. A patient who has IBS experiences diarrhea, bloating, and pain but does not want to take medication. The primary care NP should recommend: a. avoiding gluten and lactose in the diet. b. beginning aerobic exercise, such as running, every day. c. increasing water intake to eight to ten glasses per day. d. 25 g of fiber each day. d. 25 g of fiber each day. A diet with adequate fiber is the cornerstone of treatment, and 25 g per day is recommended. Unless the patient has a documented gluten or lactose malabsorption, avoiding these substances is not recommended. Water intake should be six to eight glasses per day. Regular walking is usually the best exercise.A patient who has IBS has been taking dicyclomine and reports decreased pain and diarrhea but is now having occasional constipation. The primary care NP should recommend: a. beginning therapy with a TCA. b. beginning treatment with an SSRI. c. increasing the amounts of raw fruits and vegetables in the diet. d. over-the-counter (OTC) laxatives as needed when constipated. d. over-the-counter (OTC) laxatives as needed when constipated. Patients who experience constipation may use OTC laxatives as needed. Antidepressants, such as SSRIs or TCAs, are used long-term to help with pain. Raw fruits and vegetables can increase the likelihood of bloating. A patient who has migraine headaches has begun taking timolol and 2 months after beginning this therapy reports no change in frequency of migraines. The patient's current dose is 30 mg once daily. The primary care NP should: a. tell the patient to continue taking the timolol and return in 1 month. b. obtain serum drug levels to see if the dose is therapeutic. c. change the medication to propranolol. d. increase the dose to 40 mg once daily. a. tell the patient to continue taking the timolol and return in 1 month. When giving timolol for migraine prophylaxis, the provider should inform the patient that it may take several weeks for therapy to be effective. The dose should be titrated and maintained for a minimum of 3 months before the treatment is deemed a failure. It may be necessary to change to propranolol if the therapy is not effective in 1 month. The maximum dose of timolol for migraine prophylaxis is 30 mg. Drug effectiveness is determined by patient response, not serum drug levels. A patient who has primary hyperlipidemia and who takes atorvastatin (Lipitor) continues to have LDL cholesterol of 140 mg/dL after 3 months of therapy. The primary care NP increases the dose from 10 mg daily to 20 mg daily. The patient reports headache and dizziness a few weeks after the dose increase. The NP should: a. change the patient's medication to cholestyramine (Questran). b. add ezetimibe (Zetia) and lower the atorvastatin to 10 mg daily. c. change the atorvastatin dose to 15 mg twice daily. d. recommend supplements of omega-3 along with the atorvastatin. b. add ezetimibe (Zetia) and lower the atorvastatin to 10 mg daily. When used in combination with a low-dose statin, ezetimibe has been noted to produce an additional 18% reduction in LDL. Because this patient continues to have elevated LDL along with side effects of the statin, the NP should resume the lower dose of the statin and add ezetimibe. Atorvastatin is given once daily. Cholestyramine and omega-3 supplements are not indicated. A patient who has severe arthritis and who takes nonsteroidal antiinflammatory drugs (NSAIDs) daily develops a duodenal ulcer. The patient has tried a cyclooxygenase-2 selective NSAID in the past and states that it is not as effective as the current NSAID. The primary care nurse practitioner (NP) should: a. change the NSAID to a corticosteroid. b. prescribe omeprazole (Prilosec). c. teach the patient about a bland diet. d. prescribe cimetidine (Tagamet) b. prescribe omeprazole (Prilosec). Patients with NSAID-induced ulcer should discontinue the NSAID if possible and use an acid suppressant. This patient has severe arthritis and so cannot discontinue the NSAID. In a situation such as this, a PPI is indicated. Cimetidine is a histamine-2 blocker, which would be a second-line choice, but cimetidine has many serious side effects. Bland diets are not effective in treating ulcers. Corticosteroids are not indicated. A patient who has stable angina and uses sublingual nitroglycerin tablets is in the clinic and begins having chest pain. The primary care NP administers a nitroglycerin tablet and instructs the patient to lie down. The NP's next action should be to: a. call EMS. b. give 325 mg of chewable aspirin. c. administer oxygen at 2 L/minute. d. obtain an electrocardiogram c. administer oxygen at 2 L/minute. When a patient experiences an acute attack of angina in the clinic, the primary care NP should be prepared to treat the condition. After giving nitroglycerin, oxygen should be administered. An electrocardiogram is not immediately indicated. Chewable aspirin is given if the angina is unrelieved and when the patient is being transported to the hospital. EMS should be activated if there is no pain relief 5 minutes after the first dose of nitroglycerin.A patient who has stable angina is taking nitroglycerin and a b-blocker. The patient tells the primary care NP that the cardiologist is considering adding a calcium channel blocker. The NP should anticipate that the cardiologist will prescribe: a. nicardipine (Cardene). b. nifedipine (Procardia XL). c. isradipine (DynaCirc). d. verapamil HCl (Calan). d. verapamil HCl (Calan). Nitrates and b-blockers are first-line therapy for stable angina. Calcium channel blockers should be reserved for patients who cannot take these agents or patients whose symptoms are not controlled with these agents. Verapamil is one of the calcium channel blockers that should be used. The other calcium channel blockers are not recommended for this purpose. A patient who has stable angina pectoris and a history of previous myocardial infarction takes nitroglycerin and verapamil. The patient asks the primary care nurse practitioner (NP) why it is necessary to take verapamil. The NP should tell the patient that verapamil: a. increases the force of contraction of the cardiac muscle. b. improves blood flow and oxygen delivery to the heart. c. has a positive inotropic effect to increase cardiac output. d. increases the rate of contraction of the cardiac muscle. b. improves blood flow and oxygen delivery to the heart. Verapamil decreases the force of smooth muscle contraction in the smooth muscle of the coronary and peripheral vessels; this results in coronary artery dilation, which lowers coronary resistance and improves blood flow through collateral vessels as well as oxygen delivery to ischemic areas of the heart. Calcium channel blockers do not increase the rate or force of contraction of the heart. A patient who has type 2 diabetes is seen by a primary care NP for a physical examination. The NP notes a blood pressure of 140/95 mm Hg on three occasions. A urinalysis reveals macroalbuminuria. The patient's serum creatinine is 1.9 mg/dL. Adhering to evidence-based practice, the NP should prescribe: a. enalapril maleate (Vasotec). b. losartan (Cozaar). c. captopril (Capoten). d. fosinopril sodium (Monopril). b. losartan (Cozaar). In patients with type 2 diabetes, hypertension, macroalbuminuria, and renal insufficiency (serum creatinine 1.5 mg/dL), ARBs have been shown to delay the progression of nephropathy. Losartan is an ARB. The other medications are ACE inhibitors. A patient who has type 2 diabetes mellitus will begin taking a bile acid sequestrant. Which bile acid sequestrant should the primary care NP order? a. Colesevelam (Welchol) b. Colestipol (Colestid) c. Cholestyramine (Questran Light) d. Cholestyramine (Questran) a. Colesevelam (Welchol) All bile acid sequestrants are equally effective. Colesevelam has an additional indication to improve glycemic control in adults with type 2 diabetes and so should be selected when prescribing a bile acid sequestrant for this patient. A patient who is about to begin chemotherapy expresses concern to the primary care NP about gastrointestinal side effects of the treatments. The NP should reassure the patient that: a. taking ondansetron before


Document information

Uploaded on
January 24, 2021
Number of pages
26
Written in
2020/2021
Type
Exam (elaborations)
Contains
Questions & answers
$17.99

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
grade_bender
3.9
(151)
Sold
1091
Followers
959
Items
2330
Last sold
1 week ago



Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions

Whoops! We can’t load your doc right now. Try again or contact support.